Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.175
-0.015 (-0.47%)
At close: Jun 6, 2025, 4:00 PM
3.100
-0.075 (-2.36%)
After-hours: Jun 6, 2025, 7:19 PM EDT
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Atea Pharmaceuticals stock has a target of 6.00, which predicts a 88.98% increase from the current stock price of 3.18.
Price Target: $6.00 (+88.98%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 11, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Atea Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold Maintains $6.2 → $6 | Hold | Maintains | $6.2 → $6 | +88.98% | Apr 11, 2025 |
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $2 → $6.88 | Sell → Hold | Upgrades | $2 → $6.88 | +116.69% | Aug 13, 2024 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 10, 2023 |
JP Morgan | JP Morgan | Hold Maintains $12 → $8 | Hold | Maintains | $12 → $8 | +151.97% | Mar 16, 2023 |
SVB Leerink | SVB Leerink | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +88.98% | Jan 27, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
5.78M
EPS This Year
-2.33
from -2.00
EPS Next Year
-1.86
from -2.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | 17.9M | 62.9M |
Avg | n/a | 5.8M | 38.1M |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 989.1% |
Avg | - | - | 558.5% |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.84 | -1.87 | -1.28 |
Avg | -2.33 | -1.86 | -1.44 |
Low | -2.76 | -1.82 | -1.57 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.